X hits on this document

Word document

I.EXECUTIVE ORDERS - page 156 / 359

1529 views

0 shares

0 downloads

0 comments

156 / 359

Drug Enforcement Administration to operate a substance abuse program using narcotic replacement procedures for individuals dependent upon opium, heroin, morphine, or any other derivative or synthetic drug in that classification of drugs.
Optometrist—an individual authorized by law and licensed by the Louisiana State Board of Optometry Examiners to engage in the practice of optometry.
Person—an individual, corporation, partnership, association, or any other legal entity, including government or governmental subdivision or agency.
Pharmacist—an individual authorized by law and licensed by the board to engage in the practice of pharmacy.
Pharmacy—a place authorized by law and permitted by the board to procure, possess, compound, distribute, and dispense drugs, including controlled substances.
Physician—an individual authorized by law and licensed by the Louisiana State Board of Medical Examiners to engage in the practice of medicine.
Podiatrist—an individual authorized by law and licensed by the Louisiana State Board of Medical Examiners to engage in the practice of podiatry.
Practice Affiliation—a practice relationship, collaboration, or practice under the supervision of a physician licensed to practice medicine, applicable to advanced practice registered nurses and physician assistants.
Practitioner—an individual currently licensed, registered, or otherwise authorized by the appropriate licensing board to prescribe and administer drugs in the course of professional practice.
Prescribe or Prescribing—to order a drug or device to be administered or dispensed to a specific patient.
Prescriber—an individual currently licensed, registered, or otherwise authorized by the appropriate licensing board to prescribe drugs in the course of professional practice.
Prescription or Prescription Drug Order—an order from a practitioner authorized by law to prescribe a drug or device that is patient specific and is to be preserved on file as required by law or regulation.
Researcher—an individual qualified to conduct medical, educational, or scientific experiments on animals, humans, or in laboratories which require the use of controlled substances. For the purpose of this Chapter, manufacturers which use controlled substances in the manufacturing process, but do not manufacture controlled substances as an end product, shall be considered researchers and not manufacturers as defined in R.S. 40:961(24).
Sales Representative or Professional Medical Representative—an individual employed by a manufacturer or distributor and authorized by the employer to receive, possess, and deliver controlled substances to a person licensed to possess controlled dangerous substances.
Veterinarian—an individual authorized by law and licensed by the Louisiana State Board of Veterinary Medicine to engage in the practice of veterinary medicine.

AUTHORITY NOTE:Promulgated in accordance with R.S. 40:972.

HISTORICAL NOTE:Promulgated by the Department of Health and Hospitals, Board of Pharmacy, LR 34:2127 (October 2008).

§2703.Controlled Substances

A.Classification

1.Controlled substances are specifically identified by reference, as provided in R.S. 40:961 et seq., or its successor, and 21 CFR §1308 et seq., or its successor. Schedules I, II, III, IV, and V shall, unless and until added to pursuant to R.S. 40:961 et seq., or its successor, consist of the drugs or other substances, by whatever official name, common or usual name, chemical name, or trade name designated, listed in R.S. 40:961 et seq., or its successor.

B.Schedules. Controlled substances are categorized into various schedules based upon the degrees of potential for abuse, as follows.

1.Schedule I:
a.the drug or other substance has a high potential for abuse;
b.the drug or other substance has no currently accepted medical use in treatment in the United States; and
c.there is a lack of accepted safety for use of the drug or other substance under medical supervision.
2.Schedule II:
a.the drug or other substance has a high potential for abuse;
b.the drug or other substance has a currently accepted medical use in treatment in the United States; or a currently accepted medical use with severe restrictions; and
c.abuse of the drug or other substance may lead to severe psychological or physical dependence.
d.When used, Schedule II-N (or 2N) shall refer to the non-narcotic drugs listed in Schedule II.
3.Schedule III:
a.the drug or other substance has a potential for abuse less than the drugs or other substances listed in Schedules I and II above;
b.the drug or other substance has a currently accepted medical use in treatment in the United States; and
c.abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
d,When used, Schedule III-N (or 3N) shall refer to the non-narcotic drugs listed in Schedule III.
4.Schedule IV:
a.the drug or other substance has a low potential for abuse relative to the drugs or other substances listed in schedule III;
b.the drug or other substance has a currently accepted medical use in treatment in the United States; and
c.abuse of the drug or other substance may lead to limited psychological or physical dependence relative to the drugs or other substances listed in Schedule III.
5.Schedule V:
a.the drug or other substance has a low potential for abuse relative to the drugs or other substances listed in schedule IV;
b.the drug or other substance has a currently accepted medical use in treatment in the United States; and
c.abuse of the drug or other substance may lead to limited psychological or physical dependence relative to the drugs or other substances listed in Schedule IV.

Louisiana Register   Vol. 34, No. 10   October 20, 2008

Document info
Document views1529
Page views1532
Page last viewedSun Dec 04 08:36:29 UTC 2016
Pages359
Paragraphs18243
Words293762

Comments